tm
Seeing Is Believing
tm
Seeing Is Believing
UTRS is currently covered by 3 analysts
Minerva Surgical's activity chart (see below) currently has 4 price targets and 7 ratings on display. The stock rating distribution of UTRS is 33.33% BUY and 66.67% SELL.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 81.5 days.
Highest price target for UTRS is $47, Lowest price target is $35.
Most recent stock forecast was given by ROBBIE MARCUS from JPMORGAN on 10-Aug-2022. First documented stock forecast 16-Nov-2021.
Currently out of the existing stock ratings of UTRS, 1 are a BUY (33.33%), 2 are a SELL (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$280
4 years 1 months 24 days ago
(10-Aug-2022)
0/1 (0%)
$90.2 (47.52%)
Buy
$12
4 years 1 months 25 days ago
(10-Aug-2022)
1/1 (100%)
$-23 (-65.71%)
153
Buy
$7
$6.44 (1150.00%)
$240
4 years 4 months 22 days ago
(12-May-2022)
1/3 (33.33%)
$-28 (-80.00%)
173
Buy
$14
$11 (366.67%)
$15
4 years 6 months 26 days ago
(09-Mar-2022)
0/2 (0%)
$7.2 (115.75%)
What is UTRS (Minerva Surgical) average time for price targets to be met?
Which analyst most recently updated their price target on UTRS (Minerva Surgical)?
Which analyst has the current lower performing score on UTRS (Minerva Surgical) with a proven track record?
Which analyst has the most public recommendations on UTRS (Minerva Surgical)?
Which analyst is the currently most bullish on UTRS (Minerva Surgical)?
Which analyst is the currently most reserved on UTRS (Minerva Surgical)?
